Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
- PMID: 17168998
- DOI: 10.1111/j.1574-6976.2006.00053.x
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Abstract
At the end of 2005, six European countries had implemented public immunization campaigns with serogroup C conjugate vaccines, and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W135 are infrequent causes of disease. This paper outlines recommendations on the use of conjugate vaccines in Europe based on the experience with meningococcal C conjugate (MCC) vaccines so far.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

